Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The immune-modulating drug was approved to treat the rare cancer in HIV-positive and HIV-negative people.
Immune modulator demonstrated an overall response rate of 52%
Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.